Moolec Science S.A. (MLEC)
NASDAQ: MLEC
· Real-Time Price · USD
2.46
0.02 (0.61%)
At close: Aug 15, 2025, 3:54 PM
2.42
-1.88%
After-hours: Aug 15, 2025, 04:00 PM EDT
Company Description
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape.
The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas.
It operates in the United States, Europe, and South America.
The company was founded in 2008 and is based in Luxembourg.
Moolec Science S.A.
| Country | LU |
| IPO Date | Mar 2, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 52 |
| CEO | Henk Hoogenkamp |
Contact Details
Address: 17 Boulevarrd F.W. Raiffeisen, Luxembourg, LU | |
| Website | https://moolecscience.com |
Stock Details
| Ticker Symbol | MLEC |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001937737 |
| CUSIP Number | |
| ISIN Number | LU2559000059 |
| Employer ID | 00-0000000 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Jose Lopez Lecube M.B.A. | Chief Financial Officer & Executive Director |
| Catalina Jones B.A. | Chief of Staff & Sustainability |
| Dr. Amit Dhingra Ph.D. | Chief Science Officer |
| Florencia Bottero | Corporate Counsel & Secretary of the Board |
| Henk Hoogenkamp Ph.D. | Co-Founder & Chief Product Officer |
| Martin Salinas Ph.D. | Chief of Technology & Co-Founder |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 12, 2025 | 6-K | Filing |
| Jun 18, 2025 | 6-K | Filing |
| Jun 17, 2025 | 6-K | Filing |
| Jun 17, 2025 | POS AM | Filing |
| Jun 16, 2025 | 6-K | Filing |
| Jun 16, 2025 | S-8 POS | Filing |
| Jun 16, 2025 | POS AM | Filing |
| Jun 04, 2025 | 6-K | Filing |
| May 13, 2025 | 6-K | Filing |
| Apr 29, 2025 | 6-K | Filing |